Standard InChI: InChI=1S/C28H37N6O8P/c1-5-19(6-2)14-39-26(36)18(3)33-43(38,42-20-10-8-7-9-11-20)40-15-22-24(35)27(4,37)28(16-29,41-22)23-13-12-21-25(30)31-17-32-34(21)23/h7-13,17-19,22,24,35,37H,5-6,14-15H2,1-4H3,(H,33,38)(H2,30,31,32)/t18-,22+,24+,27+,28-,43?/m0/s1
Standard InChI Key: AJUZSILXPPXOCL-MOJYSVATSA-N
Associated Targets(Human)
Hepatocyte 2737 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Liver 3974 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Caco-2 12174 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Huh-7 12904 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HEp-2 3859 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MT4 17854 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Canis familiaris 36305 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Syrian golden hamster 1610 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Hepatitis C virus 23859 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Ebolavirus 617 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human orthopneumovirus 392 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 616.61
Molecular Weight (Monoisotopic): 616.2410
AlogP: 2.70
#Rotatable Bonds: 13
Polar Surface Area: 203.55
Molecular Species: NEUTRAL
HBA: 13
HBD: 4
#RO5 Violations: 2
HBA (Lipinski): 14
HBD (Lipinski): 5
#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.23
CX Basic pKa: 0.65
CX LogP: 2.29
CX LogD: 2.29
Aromatic Rings: 3
Heavy Atoms: 43
QED Weighted: 0.16
Np Likeness Score: 0.12
References
1.Cho A, Zhang L, Xu J, Lee R, Butler T, Metobo S, Aktoudianakis V, Lew W, Ye H, Clarke M, Doerffler E, Byun D, Wang T, Babusis D, Carey AC, German P, Sauer D, Zhong W, Rossi S, Fenaux M, McHutchison JG, Perry J, Feng J, Ray AS, Kim CU.. (2014) Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients., 57 (5):[PMID:23547794][10.1021/jm400201a]
2.Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, Zhang L, Neville S, Carra E, Lew W, Ross B, Wang Q, Wolfe L, Jordan R, Soloveva V, Knox J, Perry J, Perron M, Stray KM, Barauskas O, Feng JY, Xu Y, Lee G, Rheingold AL, Ray AS, Bannister R, Strickley R, Swaminathan S, Lee WA, Bavari S, Cihlar T, Lo MK, Warren TK, Mackman RL.. (2017) Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses., 60 (5):[PMID:28124907][10.1021/acs.jmedchem.6b01594]